Forte Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementForte Biosciences, Inc. • September 4th, 2020 • Pharmaceutical preparations • New York
Forte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows:
September 4, 2020Sales Agreement • September 4th, 2020 • Forte Biosciences, Inc. • Pharmaceutical preparations
